Matt Hancock speaks out on AstraZeneca and Oxford Univeristy vaccine

The transcript discusses the Oxford AstraZeneca vaccine, highlighting its effectiveness of up to 90% in the right dosage. It emphasizes the importance of regulatory approval by the MHRA and outlines plans for vaccine rollout in the New Year. The vaccine is easier to administer than the Pfizer vaccine due to less stringent storage requirements. The speaker also touches on the ongoing strategy to suppress the virus while supporting the economy, education, and the NHS until widespread vaccination is achieved. Christmas plans are being coordinated across the UK, respecting discussions between devolved administrations and the government.

What is the reported effectiveness of the Oxford AstraZeneca vaccine in the right dosage?

• 90%

• 80%

• 95%

• 70%

Why is the Oxford AstraZeneca vaccine considered easier to administer than the Pfizer vaccine?

• It is cheaper

• It does not need to be stored at minus 70 degrees

• It can be stored at room temperature

• It requires fewer doses

When is the bulk of the vaccine rollout expected to occur?

• Next month

• In the summer

• In the New Year

• By the end of the year

What is the strategy mentioned for controlling the virus until vaccination is widespread?

• Focusing only on healthcare

• Relying solely on vaccines

• Suppressing the virus while supporting the economy and education

• Complete lockdown

Why is there a delay in announcing Christmas plans?

• Lack of government consensus

• Trying to agree on plans across the Four Nations of the UK

• Waiting for more vaccine data

• Public opposition